RQ3025
/ Walvax
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
January 24, 2024
A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults
(clinicaltrials.gov)
- P=N/A | N=376 | Completed | Sponsor: Affiliated Hospital of Yunnan University | Recruiting ➔ Completed
Trial completion • Infectious Disease • Novel Coronavirus Disease
July 09, 2023
A Study to Investigate the Safety, Immunogenicity of Bivalent mRNA Vaccine RQ3027 and RQ3025 as a Booster Dose in Healthy Adults
(clinicaltrials.gov)
- P=N/A | N=420 | Recruiting | Sponsor: Affiliated Hospital of Yunnan University | N=280 ➔ 420
Enrollment change • Infectious Disease • Novel Coronavirus Disease • IL4
June 18, 2023
A Study to Investigate the Safety, Immunogenicity of a Bivalent mRNA Vaccine RQ3025 as a Booster Dose in Healthy Adults
(clinicaltrials.gov)
- P=N/A | N=280 | Recruiting | Sponsor: Affiliated Hospital of Yunnan University
New trial • Infectious Disease • Novel Coronavirus Disease • IL4
1 to 3
Of
3
Go to page
1